Research Article

Predictors of Loss to Follow-Up among HIV-Infected Adults after Initiation of the First-Line Antiretroviral Therapy at Arba Minch General Hospital, Southern Ethiopia: A 5-Year Retrospective Cohort Study

Table 7

Predictors of loss to follow-up among adult patients attending the ART clinic at Arba Minch General Hospital, Southern Ethiopia, 2019 ().

VariablesCategoriesLTFUCensoredcHR (95% CI)aHR (95% CI)

Age(years)<35322182.53 (1.35-4.75)1.96 (1.92-4.00)
≥35142441
SexMale192000.95 (0.53-1.71)
Female272621
ResidenceUrban2634911.98 (1.02-3.83)
Rural201132.42 (1.35-4.34)
Educational statusNo formal education101021.92 (0.53-6.99)
Primary191761.97 (0.58-6.66)
Secondary141242.10 (0.60-7.32)
Tertiary and above3601
Occupation statusEmployed612411
Non-employed403382.26 (0.96-5.34)1.96 (0.73-5.27)
Marital statusSingle5621
Married292691.22 (0.47-3.16)
Divorced8821.21 (0.39-3.69)
Widowed4490.99 (0.27-3.71)
Disclosure statusDisclosed4344211
Not-disclosed3204.07 (1.25-13.3)0.93 (0.22-3.87)
Substance useYes4720.51 (0.18-1.41)0.58 (0.19-1.71)
No4239011
Baseline weight≤60 kg3135311
>60 kg151091.48 (0.80-2.75)2.19 (1.11-4.37)
Baseline functional statusWorking4135411
Ambulatory and bedridden51080.54 (0.21-1.37)1.11 (0.32-3.92)
Level of adherenceGood3240811
Fair2209.38 (2.2-39.99)11.5 (2.1-61.1)
Poor123412.49 (6.3-24.8)12.03 (5.426.7)
Baseline WHO stageStage 132239 90 118 1511
Stage 270.65 (0.29-1.50)0.69 (0.26-1.81)
Stage 360.42 (0.18-1.01)0.65 (0.23-1.89)
Stage 410.45 (0.06-3.31)2.14 (0.21-22.3)
Baseline CD4 count< 200161611.31 (0.71-2.39)
≥ 200303011
TB at startYes4800.57 (0.20-1.58)
No423821
OIs other than TBYes4810.57 (0.20-1.58)
No423811
CPT at startYes272571
No192051.01 (0.56-1.81)
Comedication other than CPTYes1101.19 (0.16-8.69)
No454521
Test-startYes2521311
No212490.45 (0.25-0.81)0.84 (0.43-1.6)
Numbers of pills/day.One44447
Two and above2150 .86 (0.2-3.57)

Indicates a value < 0.05; 1: reference category; cHR: crude hazard ratio; aHR: adjusted hazard ratio; CI: confidence interval; kg: kilogram; TB: tuberculosis; OIs: opportunistic infections; CD4: cluster of differentiation; CPT: cotrimoxazole prophylaxis therapy; LTFU: loss to follow-up.